Children
Sign in to add traineeSadik H Kassim | research scientist | National Cancer Institute (Cell & Gene Therapy Tree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Kalaitsidou M, Moon OR, Sykorova M, et al. (2023) Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infiltrating lymphocytes. Frontiers in Immunology. 14: 1256491 |
Schmidt E, Mardilovich K, Bath N, et al. (2021) 373 Enhancement of TCR-engineered T-cells targeting MAGE-A4 antigen by co-expression of CD8α and inhibition of AKT signaling during ex vivo T-cell expansion Journal For Immunotherapy of Cancer. 9: A401-A401 |
Hong D, Clarke J, Johanns T, et al. (2020) 379 Initial safety, efficacy, and product attributes from the SURPASS trial with ADP-A2M4CD8, a SPEAR T-cell therapy incorporating an affinity optimized TCR targeting MAGE-A4 and a CD8α co-receptor Journal For Immunotherapy of Cancer. 8: A404-A404 |
Mardilovich K, Wang L, Kenneil R, et al. (2020) 95 Inhibition of AKT signaling during expansion of TCR-engineered T-cells from patient leukocyte material generates SPEAR T-cells with enhanced functional potential in vitro Journal For Immunotherapy of Cancer. 8: A106-A106 |
Xue Q, Bettini E, Paczkowski P, et al. (2017) Single-cell multiplexed cytokine profiling of CD19 CAR-T cells reveals a diverse landscape of polyfunctional antigen-specific response. Journal For Immunotherapy of Cancer. 5: 85 |
Goff SL, Dudley ME, Citrin DE, et al. (2016) Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology |
Wang J, Dudley M, Choquette T, et al. (2016) An Innovative in Vitro Potency Assay Designed to Predict the Fate of Chimeric Antigen Receptors Modified T Cell Therapy Post Infusion in ALL Blood. 128: 5830-5830 |
Stevanovi? S, Draper LM, Langhan MM, et al. (2015) Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 1543-50 |
Zhang L, Morgan RA, Beane JD, et al. (2015) Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 2278-88 |
Robbins PF, Kassim SH, Tran TL, et al. (2015) A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1019-27 |